![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 17, 2021 9:49:36 PM
Zyesami will be in the I-spy covid trials. a clinical trial ordered by the department of health and human services & defense department. It was posted by dmsrz on this forum today. Read his informative post & learn more about this drug.....
It was chosen for that before their current trial had completed so they didn't know the results. Had they seen the trial's results, they maybe wouldn't have been picked. But I think there should be an inhaler trial. An inhaler can be done cheaply and on an outpatient basis. That could be a game changer. And an inhaler might deliver the drug more effectively to the lungs. But all of this is conjecture. All that matters is the results of double blind placebo controlled studies. So far RLF-100 has failed in that respect. And the belief that future studies will succeed is solely based on faith.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM